Total Payments
$2,923
2024 Payments
$713.17
Companies
34
Transactions
188
Medicare Patients
2,185
Medicare Billing
$201,527
Payment Breakdown by Category
Food & Beverage$2,923 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,923 | 188 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $381.17 | 25 | $0 (2024) |
| PFIZER INC. | $354.61 | 24 | $0 (2024) |
| Lilly USA, LLC | $284.01 | 16 | $0 (2024) |
| Novo Nordisk Inc | $254.00 | 17 | $0 (2024) |
| GlaxoSmithKline, LLC. | $236.12 | 15 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $232.07 | 16 | $0 (2024) |
| Amgen Inc. | $206.92 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $127.60 | 7 | $0 (2024) |
| UPSHER-SMITH LABORATORIES LLC | $83.59 | 5 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $72.66 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $713.17 | 41 | Lilly USA, LLC ($159.61) |
| 2023 | $449.38 | 27 | PFIZER INC. ($81.06) |
| 2022 | $549.44 | 34 | GlaxoSmithKline, LLC. ($73.99) |
| 2021 | $732.30 | 52 | AbbVie Inc. ($211.76) |
| 2020 | $348.46 | 25 | Boehringer Ingelheim Pharmaceuticals, Inc. ($139.77) |
| 2019 | $130.22 | 9 | Novo Nordisk Inc ($27.31) |
All Payment Transactions
188 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Inflammation | ||||||
| 11/08/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: UROLOGY | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: DIABETES | ||||||
| 09/24/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/19/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Hepatitis B Vaccine | ||||||
| 06/18/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Diabetes | ||||||
| 06/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Diabetes | ||||||
| 05/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: PAIN | ||||||
| 05/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Diabetes | ||||||
| 05/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: PAIN | ||||||
| 05/03/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Hepatitis B Vaccine | ||||||
| 04/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/26/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Psychology/Psychiatric | ||||||
| 04/24/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Diabetes | ||||||
| 04/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: RESPIRATORY | ||||||
| 03/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Diabetes | ||||||
| 03/26/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 675 | 874 | $171,226 | $69,545 |
| 2022 | 15 | 661 | 825 | $135,335 | $58,290 |
| 2021 | 12 | 473 | 597 | $99,075 | $44,996 |
| 2020 | 12 | 376 | 490 | $77,060 | $28,696 |
Total Patients
2,185
Total Services
2,786
Medicare Billing
$201,527
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 169 | 322 | $78,246 | $25,696 | 32.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 131 | 131 | $32,488 | $16,010 | 49.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 35 | 35 | $18,550 | $9,560 | 51.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 68 | 70 | $10,276 | $4,956 | 48.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 45 | $7,740 | $2,507 | 32.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 71 | 73 | $4,228 | $2,088 | 49.4% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 14 | 14 | $3,682 | $1,799 | 48.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 13 | $4,459 | $1,764 | 39.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $3,498 | $1,729 | 49.4% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 34 | 34 | $2,720 | $1,258 | 46.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 35 | 35 | $1,960 | $972.40 | 49.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 33 | 65 | $2,015 | $599.76 | 29.8% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 14 | 14 | $1,208 | $533.68 | 44.2% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 12 | 12 | $156.00 | $73.32 | 47.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 181 | 304 | $65,221 | $24,143 | 37.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 103 | 103 | $23,543 | $12,817 | 54.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 16 | 16 | $7,904 | $4,466 | 56.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 60 | 60 | $8,400 | $4,112 | 49.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 45 | 58 | $8,576 | $3,247 | 37.9% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 13 | 14 | $4,838 | $2,180 | 45.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 69 | 69 | $3,846 | $1,859 | 48.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 12 | $3,626 | $1,509 | 41.6% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 42 | 42 | $3,360 | $1,497 | 44.6% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 23 | 23 | $1,840 | $825.64 | 44.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 19 | 19 | $830.00 | $515.74 | 62.1% |
About Dr. Megan Schultz, MD
Dr. Megan Schultz, MD is a Internal Medicine healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2016. The National Provider Identifier (NPI) number assigned to this provider is 1831551076.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Megan Schultz, MD has received a total of $2,923 in payments from pharmaceutical and medical device companies, with $713.17 received in 2024. These payments were reported across 188 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($2,923).
As a Medicare-enrolled provider, Schultz has provided services to 2,185 Medicare beneficiaries, totaling 2,786 services with total Medicare billing of $201,527. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Lexington, KY
- Active Since 03/27/2016
- Last Updated 07/08/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1831551076
Products in Payments
- TRELEGY ELLIPTA (Drug) $195.66
- NURTEC ODT (Drug) $191.84
- JARDIANCE (Drug) $178.76
- MOUNJARO (Drug) $163.80
- UBRELVY (Drug) $149.79
- Otezla (Drug) $106.70
- ELIQUIS (Drug) $101.13
- LEQVIO (Drug) $98.63
- Aimovig (Biological) $84.44
- Ozempic (Drug) $82.69
- SYNTHROID (Drug) $79.93
- VRAYLAR (Drug) $68.32
- COMIRNATY (Biological) $49.26
- TOSYMRA (Drug) $48.87
- TRULICITY (Drug) $48.74
- SOLIQUA 100/33 (Biological) $48.43
- SPIRIVA RESPIMAT (Drug) $47.76
- OFEV (Drug) $47.13
- GEMTESA (Drug) $45.00
- Kerendia (Drug) $44.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lexington
Dr. Firas Badin, M.d, M.D
Internal Medicine — Payments: $1.9M
Internal Medicine $1.9M
Dennis Doherty, Md, MD
Internal Medicine — Payments: $686,622
Internal Medicine $686,622
Dr. Robert Sawyer, M.d, M.D
Internal Medicine — Payments: $232,104
Internal Medicine $232,104
David Mannino, Md, MD
Internal Medicine — Payments: $140,029
Internal Medicine $140,029
Dr. Anastasia Jandes, Md, MD
Internal Medicine — Payments: $90,742
Internal Medicine $90,742
Gloria Vigliani, M.d, M.D
Internal Medicine — Payments: $89,452
Internal Medicine $89,452